期刊文献+

Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitis 被引量:9

Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitis
下载PDF
导出
摘要 AIM: To elucidate the possible crosstalk between angiogenesis, cytokeratin-18 (CK-18), and insulin resistance (IR) especially in patients with non-alcoholic steatohepatitis (NASH).METHODS: Twenty-eight patients with NASH and 11 with simple fatty liver disease (FL) were enrolled in this study and underwent clinicopathological examination. The measures of angiogenesis, CK-18, and IR employed were CD34-immunopositive vessels, CK-18immunopositive cells, and homeostasis model assessment of IR (HOMA-IR), respectively. The correlations of these factors with NASH were elucidated.RESULTS: Significant development of hepatic neovascularization was observed only in NASH, whereas almost no neovascularization could be observed in FL and healthy liver. The degree of angiogenesis was almost parallel to liver fibrosis development, and both parameters were positively correlated. Similarly, CK-18expression and HOMA-R were signifi cantly increased in NASH as compared with FL and healthy liver. Furthermore, CK-18 and HOMA-IR were also positively correlated with the degree of neovascularization. CONCLUSION: These results indicate that the crosstalk between angiogenesis, CK-18, and IR may play an important role in the onset and progression of NASH. AIM: To elucidate the possible crosstalk between angiogenesis, cytokeratin-18 (CK-18), and insulin resistance (IR) especially in patients with non-alcoholic steatohepatitis (NASH). METHODS: Twenty-eight patients with NASH and 11 with simple fatty liver disease (FL) were enrolled in this study and underwent clinicopathological examination. The measures of angiogenesis, CK-18, and IR employed were CD34-immunopositive vessels, CK-18- immunopositive cells, and homeostasis model assessment of IR (HOMA-IR), respectively. The correlations of these factors with NASH were elucidated. RESULTS: Significant development of hepatic neo- vascularization was observed only in NASH, whereas almost no neovascularization could be observed in FL and healthy liver. The degree of angiogenesis was almost parallel to liver fibrosis development, and both parameters were positively correlated. Similarly, CK-18 expression and HOMA-R were significantly increased in NASH as compared with FL and healthy liver. Further- more, CK-18 and HOMA-IR were also positively corre- lated with the degree of neovascularization. CONCLUSION: These results indicate that the crosstalk between angiogenesis, CK-18, and IR may play an important role in the onset and progression of NASH.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第41期5193-5199,共7页 世界胃肠病学杂志(英文版)
关键词 ANGIOGENESIS Cytokeratin-18 Fatty liver Insulin resistance Non-alcoholic steatohepatitis Liver fibrosis 胰岛素抵抗 血管生成 细胞角蛋白 脂肪肝 酒精性 串扰 肝炎 佛罗里达州
  • 相关文献

参考文献41

  • 1Angulo P.Nonalcoholic fatty liver disease.N Engl J Med 2002; 346:1221-1231.
  • 2Reid AE.Nonalcoholic steatohepatitis.Gastroenterology 2001; 121:710-723.
  • 3Carmeliet P.Angiogenesis in life,disease and medicine.Nature 2005; 438:932-936.
  • 4Kalluri R,Sukhatme VP.Fibrosis and angiogenesis.Curr Opin Nephrol Hypertens 2000; 9:413-418.
  • 5Yoshiji H,Kuriyama S,Yoshii J,Ikenaka Y,Noguchi R,Hicklin DJ,Wu Y,Yanase K,Namisaki T,Yamazaki M,Tsujinoue H,Imazu H,Masaki T,Fukui H.Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis.2003; 52:1347-1354.
  • 6Medina J,Caveda L,Sanz-Cameno P,Arroyo AG,Martín-Vílchez S,Majano PL,García-Buey L,Sánchez-Madrid F,Moreno-Otero R.Hepatocyte growth factor activates endothelial proangiogenic mechanisms relevant in chronic hepatitis C-associated neoangiogenesis.J Hepatol 2003; 38:660-66.
  • 7Kitade M,Yoshiji H,Kojima H,Ikenaka Y,Noguchi R,Kaji K,Yoshii J,Yanase K,Namisaki T,Asada K,Yamazaki M,Tsujimoto T,Akahane T,Uemura M,Fukui H.Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats.Hepatology 2006; 44:983-991.
  • 8Kitade M,Yoshiji H,Kojima H,Ikenaka Y,Noguchi R,Kaji K,Yoshii J,Yanase K,Namisaki T,Yamazaki M,Tsujimoto T,Moriya K,Kawaratani H,Akahane T,Fukui H.Neovascularization and oxidative stress in the progression of non-alcoholic steatohepatitis.Mol Med Report 2008; 1:543-548.
  • 9Canbay A,Friedman S,Gores GJ.Apoptosis:the nexus of liver injury and fibrosis.Hepatology 2004; 39:273-278.
  • 10Wieckowska A,Zein NN,Yerian LM,Lopez AR,McCullough AJ,Feldstein AE.In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease.Hepatology 2006; 44:27-33.

同被引文献122

  • 1Carmen Fierbinteanu-Braticevici,Ion Dina,Ana Petrisor,Laura Tribus,Lucian Negreanu,Catalin Carstoiu.Noninvasive investigations for non alcoholic fatty liver disease and liver fi brosis[J].World Journal of Gastroenterology,2010,16(38):4784-4791. 被引量:21
  • 2中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南[J].中国肝脏病杂志(电子版),2010,2(4):49-53. 被引量:384
  • 3Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1513
  • 4Yusuf Yilmaz,Enver Dolar,Engin Ulukaya,Semra Akgoz,Murat Keskin,Murat Kiyici,Sibel Aker,Arzu Yilmaztepe,Selim Gurel,Macit Gulten,Selim Giray Nak.Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis[J].World Journal of Gastroenterology,2007,13(6):837-844. 被引量:19
  • 5邵亮,李南方.脂肪因子与非酒精性脂肪肝[J].国际消化病杂志,2007,27(2):131-133. 被引量:4
  • 6Neuschwander-Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology . 2003
  • 7Ford ES,Giles WH,Mokdad AH.Increasing prevalence of the metabolic syndrome among U.S. Adults. Diabetes Care . 2004
  • 8Charlton M,Angulo P,Chalasani N,Merriman R,Viker K,Charatcharoenwitthaya P,Sanderson S,Gawrieh S,Krishnan A,Lindor K.Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease. Hepatology . 2008
  • 9Dixon JB,Bhathal PS,O’Brien PE.Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology . 2001
  • 10Kleiner DE,Brunt EM,Van Natta M,Behling C,Contos MJ,Cummings OW,Ferrell LD,Liu YC,Torbenson MS,Unalp- Arida A,Yeh M,McCullough AJ,Sanyal AJ.Design and validation of a histological scoring system for nonalcoholicfatty liver disease. Hepatology . 2005

引证文献9

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部